University of Michigan Rogel Cancer Center

Site:	University of Michigan Rogel Cancer Center	Go to their website
Address:	1500 East Medical Center Dr Floor B1, Reception E
City:	Ann Arbor
State:	MI
Zip:	48109
Country:	USA

Phase	Trial	Trial Status	Site Status	Drug [desc]	NCT#
3	(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST	Active, not recruiting	Active	Avapritinib or Regorafenib	NCT03465722